GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » EV-to-FCF

Tourmaline Bio (Tourmaline Bio) EV-to-FCF : (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tourmaline Bio's Enterprise Value is $169.34 Mil. Tourmaline Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Tourmaline Bio's EV-to-FCF for today is .

The historical rank and industry rank for Tourmaline Bio's EV-to-FCF or its related term are showing as below:

TRML' s EV-to-FCF Range Over the Past 10 Years
Min: -274.62   Med: 0   Max: 0
Current: -6.02

TRML's EV-to-FCF is ranked worse than
100% of 390 companies
in the Biotechnology industry
Industry Median: 6.365 vs TRML: -6.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Tourmaline Bio's stock price is $14.50. Tourmaline Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.240. Therefore, Tourmaline Bio's PE Ratio for today is At Loss.


Tourmaline Bio EV-to-FCF Historical Data

The historical data trend for Tourmaline Bio's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio EV-to-FCF Chart

Tourmaline Bio Annual Data
Trend Dec21 Dec22 Dec23
EV-to-FCF
- - -11.72

Tourmaline Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - - - -11.72

Competitive Comparison of Tourmaline Bio's EV-to-FCF

For the Biotechnology subindustry, Tourmaline Bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tourmaline Bio's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's EV-to-FCF falls into.



Tourmaline Bio EV-to-FCF Calculation

Tourmaline Bio's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=169.338/0
=

Tourmaline Bio's current Enterprise Value is $169.34 Mil.
Tourmaline Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tourmaline Bio  (NAS:TRML) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tourmaline Bio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.50/-0.240
=At Loss

Tourmaline Bio's share price for today is $14.50.
Tourmaline Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.240.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Tourmaline Bio EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tourmaline Bio (Tourmaline Bio) Business Description

Traded in Other Exchanges
N/A
Address
27 West 24th Street, Suite 702, New York, NY, USA, 10010
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.